Rheumatoid Arthritis Clinical Trial
Official title:
A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System
Verified date | October 2023 |
Source | Zimmer Biomet |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The primary purpose of this study is to evaluate the clinical and radiographic performance of the G7 Acetabular Cup System.
Status | Active, not recruiting |
Enrollment | 315 |
Est. completion date | April 2025 |
Est. primary completion date | April 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis - Rheumatoid arthritis - Correction of functional deformity - Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques - Revision procedures where other treatment or devices have failed - 18 years of age or older - Subjects willing to return for follow-up evaluations Exclusion Criteria: - Infection, sepsis and osteomyelitis - Subjects unable to cooperate with and complete the study - Neurological conditions affecting movement - Pregnancy |
Country | Name | City | State |
---|---|---|---|
France | Clermont-Ferrand Hospital | Clermont-Ferrand | |
Germany | University of Würzburg, Orthopedic | Würzburg | |
Ireland | Midwestern Regional Orthopaedic Hospital | Limerick | |
Netherlands | Reinier de Graaf Groep | Delft | |
Spain | Hospital El Bierzo | Ponferrada | |
United States | University Orthopedic Specialists | Tucson | Arizona |
Lead Sponsor | Collaborator |
---|---|
Zimmer Biomet |
United States, France, Germany, Ireland, Netherlands, Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Harris Hip Score | The Harris Hip Scale (HHS) was developed to assess the results of hip surgery, and is intended to evaluate various hip disabilities and methods of treatment in adults. The original version was published 1969. The HHS is an outcome measure administered by a qualified health care professional, such as a physician or a physical therapist.
The HHS is a measure of dysfunction so the higher the score, the better the outcome for the individual. The maximum score possible is 100. Results can be interpreted with the following: <70 = poor result; 70-80 = fair, 80-90 = good, and 90-100 = excellent. |
2 Year post-operative | |
Secondary | Oxford Hip Score | The Oxford Hip Score (OHS) is a standard patient-reported outcome measure tool designed to assess function and pain in patients undergoing total hip replacement (THR). Each item has five possible responses. Responses go from 1 = least difficult to 5= most difficult. Item scores are summed to give a total score from anywhere between 12 and 60. The lower the score, the better the outcome. | 1 Year post-operative | |
Secondary | Oxford Hip Score | The Oxford Hip Score (OHS) is a standard patient-reported outcome measure tool designed to assess function and pain in patients undergoing total hip replacement (THR). Each item has five possible responses. Responses go from 1 = least difficult to 5= most difficult. Item scores are summed to give a total score from anywhere between 12 and 60. The lower the score, the better the outcome. | 2 Year post-operative | |
Secondary | Oxford Hip Score | The Oxford Hip Score (OHS) is a standard patient-reported outcome measure tool designed to assess function and pain in patients undergoing total hip replacement (THR). Each item has five possible responses. Responses go from 1 = least difficult to 5= most difficult. Item scores are summed to give a total score from anywhere between 12 and 60. The lower the score, the better the outcome. | 5 Year post-operative | |
Secondary | Radiographic Evaluation | Radiolucencies (mm), Stability, Angle of Inclination (degree). The degree of osseous-fixation will be graded using the following system; 0-1mm radiolucencies will be classed as fixated; >1-2mm radiolucencies will be classed as not fixated; >2mm radiolucencies will be classed as unstable. If more than 50% of the 3 zones have radiolucencies of greater than 1mm, then the implant is considered not to be well fixed.
The angle of Inclination is the angle between the plane of the acetabular cup and the transichial line. |
1 Year post-operative | |
Secondary | Radiographic Evaluation | Radiolucencies (mm), Stability, Angle of Inclination (degree). The degree of osseous-fixation will be graded using the following system; 0-1mm radiolucencies will be classed as fixated; >1-2mm radiolucencies will be classed as not fixated; >2mm radiolucencies will be classed as unstable. If more than 50% of the 3 zones have radiolucencies of greater than 1mm, then the implant is considered not to be well fixed.
The angle of Inclination is the angle between the plane of the acetabular cup and the transichial line. |
2 Year post-operative | |
Secondary | Radiographic Evaluation | Radiolucencies (mm), Stability, Angle of Inclination (degree). The degree of osseous-fixation will be graded using the following system; 0-1mm radiolucencies will be classed as fixated; >1-2mm radiolucencies will be classed as not fixated; >2mm radiolucencies will be classed as unstable. If more than 50% of the 3 zones have radiolucencies of greater than 1mm, then the implant is considered not to be well fixed.
The angle of Inclination is the angle between the plane of the acetabular cup and the transichial line. |
5 Year post-operative | |
Secondary | Survivorship | Questionnaire | 7 Year post-operative | |
Secondary | Survivorship | Questionnaire | 10 Year post-operative | |
Secondary | Adverse Events | Adverse events will be documented according to ISO 14155:2011 definitions previously described. For the purposes of this study, only adverse events meeting SAE, ADE, SADE, and USADE criteria will be included, unless otherwise reported at the discretion of the investigator. | Up to 10 years postoperatively |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |